# US 2026/0242428 A1 · Polyethylenimine-modified cry proteins and their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0242428 A1
- Document ID: US20260242428A1
- Status: Published application
- Kind: A1
- Application number: 19/178,694
- Filed: 2025-04-14
- Published: 2026-08-20
- Earliest claimed: 2024-04-19
- Assignees: The Chinese University of Hong Kong
- Applicants: The Chinese University of Hong Kong
- Inventors: Michael CHAN; Marianne LEE; Reza YEKTA; Xu XIONG
- Web page: https://patentgrep.com/patent/US20260242428A1

## CPC

- C07K 14/325: Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 9/0016: {with NAD or NADP as acceptor (1.4.1)}
- C12N 9/0093: {acting on CH or CH2 groups (1.17)}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N 9/88: Lyases (4.)
- C12N 9/96: Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
- C12N 11/00: Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N 11/02: Enzymes or microbial cells immobilised on or in an organic carrier
- C12N 11/04: entrapped within the carrier, e.g. gel or hollow fibres
- C12N 11/089: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N 11/18: Multi-enzyme systems
- C12P 13/001: {Amines; Imines}
- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- C12Y 102/01002: Formate dehydrogenase (1.2.1.2)
- C12Y 104/01009: Leucine dehydrogenase (1.4.1.9)
- C12Y 305/03001: Arginase (3.5.3.1)
- C12Y 401/01017: Ornithine decarboxylase (4.1.1.17)
- C12Y 401/01018: Lysine decarboxylase (4.1.1.18)
- C07K 2319/00: Fusion polypeptide
- C07K 2319/735: containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
- C12Y 101/01001: Alcohol dehydrogenase (1.1.1.1)
- C12Y 101/01027: L-Lactate dehydrogenase (1.1.1.27)
- C12Y 117/01: with NAD+ or NADP+ as acceptor (1.17.1)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present invention provides a system for immobilizing recombinantly produced proteins, especially enzymes useful for catalyzing various chemical reactions, and cofactors required for the reactions by way of polyethylenimine (PEI)-modified protein crystals. Related compositions and as well as methods of making and using the immobilized proteins and cofactors are also described.

## Claims

### Claim 1

A protein crystal formed by a Cry protein, a crystal-forming variant thereof, a crystal-forming fragment thereof, or a fusion polypeptide comprising the Cry protein, the variant, or the fragment fused to a heterologous protein, wherein the protein crystal is modified with polyethylenimine (PEI).

### Claim 2 (depends on 1)

The protein crystal of claim 1, wherein the Cry protein is Cry3Aa or Cry1Ab.

### Claim 3 (depends on 1)

The protein crystal of claim 1, which is formed by (1) a fusion polypeptide comprising a Cry protein, a crystal-forming variant of the Cry protein, or a crystal-forming fragment of the Cry protein fused to a heterologous protein: or (2) a Cry protein, a crystal-forming variant of the Cry protein, or a crystal-forming fragment of the Cry protein and comprises a heterologous protein entrapped within.

### Claim 4

(canceled)

### Claim 5 (depends on 3)

The protein crystal of claim 3, wherein the heterologous protein is an enzyme.

### Claim 6 (depends on 5)

The protein crystal of claim 5, wherein enzyme is a formate dehydrogenase (FDH), leucine dehydrogenase (LDH), human arginase (hArg), ornithine decarboxylase (ODC), alcohol dehydrogenase (ADH), mandelate dehydrogenase (MDH), carbonyl reductase (CBR), reductive aminase (RedAm), or cytochrome P450 (CYP or P450).

### Claim 7 (depends on 3)

The protein crystal of claim 3, wherein the fusion polypeptide comprises a Cry protein, a crystal-forming variant of the Cry protein, or a crystal-forming fragment of the Cry protein fused to an enzyme.

### Claim 8 (depends on 7)

The protein crystal of claim 7, wherein the fusion polypeptide is a Cry3Aa-ADH fusion, Cry3Aa-FDH fusion, Cry3Aa-LDH fusion, Cry3Aa-MDH fusion, Cry3Aa-P450 fusion, Cry1Ab-hArg fusion, Cry1Ab-ODC fusion, or Cry1Ab-P450 fusion.

### Claim 9 (depends on 5)

The protein crystal of claim 5, wherein the protein crystal is bound with a cofactor required for a chemical reaction catalyzed by the enzyme.

### Claim 10 (depends on 9)

The protein crystal of claim 9, wherein the cofactor is a phosphorylated cofactor.

### Claim 11 (depends on 10)

The protein crystal of claim 10, wherein the phosphorylated cofactor is nicotinamide adenine dinucleotide (NADH), flavin adenine dinucleotide (FADH), or pyridoxal phosphate (PLP).

### Claim 12 (depends on 9)

The protein crystal of claim 9, wherein (1) the enzyme is an ADH, FDH, LDH, MDH, CBR, or RedAm and the phosphorylated cofactor is NADH: or (2) the enzyme is an ODC and the phosphorylated cofactor is PLP.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The protein crystal of claim 1, comprising two fusion polypeptides.

### Claim 15 (depends on 1)

A composition comprising the protein crystal of claim 1.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the protein crystal comprises an enzyme capable of catalyzing a substrate in a chemical reaction and a cofactor required for the reaction, and wherein composition further comprises the substrate.

### Claim at position 17

17-21. (canceled)

### Claim 22 (depends on 5)

A method for performing a chemical reaction, comprising the step of incubating the protein crystal of claim 5 with a substrate to the enzyme under conditions permissible for the substrate to be catalyzed by the enzyme in the chemical reaction.

### Claim 23 (depends on 22)

The method of claim 22, wherein the enzyme is a formate dehydrogenase (FDH), leucine dehydrogenase (LDH), human arginase (hArg), ornithine decarboxylase (ODC), alcohol dehydrogenase (ADH), mandelate dehydrogenase (MDH), carbonyl reductase (CBR), or reductive aminase (RedAm), or cytochrome P450 (CYP or P450).

### Claim 24 (depends on 22)

The method of claim 22, wherein (1) the enzyme is an ADH, FDH, LDH, MDH, CBR, or RedAm and the protein crystal is bound with NADH; or (2) the enzyme is an ODC and the protein crystal is bound with PLP.

### Claim at position 21

25-26. (canceled)

### Claim 27 (depends on 18)

The method of claim 18, further comprising, after the reaction is completed, removing the reaction product and reusing the crystal in a second reaction.

### Claim 28 (depends on 1)

An in vitro method of immobilizing a cofactor by incubating the cofactor with the protein crystal of claim 1 in a solution and allowing the cofactor to bind to the protein crystal.

### Claim at position 24

29-31. (canceled)

### Claim 32 (depends on 1)

A method of delivering a protein of interest to a target cell, comprising contacting the target cell with a pre-formed complex between the protein of interest and the protein crystal of claim 1.

### Claim at position 26

33-35. (canceled)
